Skokie, ILNCT06928142Now EnrollingIRB Ready

Sjogren's Disease Clinical Trial in Skokie, IL

Access cutting-edge sjogren's disease treatment through this clinical trial at a research site in Skokie. Study-provided care at no cost to qualified participants.

Sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.

Quick Self-Assessment

See if you qualify for this Skokie location

Preparing your pre-screening questions...

Expert Care in Skokie

Access sjogren's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sjogren's disease treatment provided free

Apply for This Skokie Location

Check if you qualify for this sjogren's disease clinical trial in Skokie, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Skokie

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Skokie site if eligible
  4. 4Begin participation

About This Sjogren's Disease Study in Skokie

This is a phase 2 study to evaluate the effects of sibeprenlimab 400 mg administered subcutaneously (SC) every 4 (Q4) weeks as an add-on to background treatment in participants with Sjögren's disease.

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Who Can Participate

Inclusion Criteria

Diagnosed with Sjögren's disease.
ESSDAI score (which measures disease activity) must be 5 or higher.
Salivary flow rate must be at least 0.05 mL/min.
Serum IgG level must be higher than 900 mg/dL.
Must be able to communicate well with the investigator and agree to follow the trial requirements.
Participants can continue certain medications (hydroxychloroquine, methotrexate, leflunomide, or azathioprine) if they have been on a stable dose for at least 30 days.
Corticosteroid dose must be stable and no more than 10 mg/day for at least 30 days.
Test positive for anti-Ro52 and/or anti-Ro60 antibodies. Key

Exclusion Criteria

Another active autoimmune rheumatic disease.
Prior use of B-cell depleting therapy or prohibited immunosuppressants.
Significant comorbidities including uncontrolled type 2 diabetes, malignancy, and chronic and/or acute infections.
Suicidal ideation or behavior based on the Patient Health Questionnaire-9 (PHQ-9).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Skokie?

Yes, this clinical trial (NCT06928142) has an active research site in Skokie, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sjogren's Disease Treatment Options in Skokie, IL

If you're searching for sjogren's disease treatment options in Skokie, IL, this clinical trial (NCT06928142) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Skokie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sjogren's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sjogren's disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Skokie, IL

See all ankylosing spondylitis clinical trials recruiting in Skokie — not just this study.

Browse Ankylosing Spondylitis Trials in Skokie →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsSjogrens Syndrome TrialsAll Conditions →

Ready to Join in Skokie?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Skokie, IL